Back to Search Start Over

Twenty years of follow-up among survivors of childhood and young adult acute myeloid leukemia

Authors :
Marilyn Stovall
Charles A. Sklar
Stella M. Davies
Barry D. Anderson
Jerry Finklestein
Stephen Qualman
Daniel C. Bowers
Gerald S. Gilchrist
Maura O'Leary
Julie Blatt
Gail E. Tomlinson
Lillian R. Meacham
Sue Hammond
Robert J. Hayashi
Jane Sande
Paul C. Nathan
Lorrie F. Odom
Robert E. Goldsby
Suwen Li
W. Anthony Smithson
George R. Buchanan
Kimberly Whelan
Lisa Diller
Greg Armstrong
Thomas W. Pendergrass
Peter D. Inskip
John Mulvihill
Frederick P. Li
Debra L. Friedman
Vilmarie Rodriguez
Melissa M. Hudson
Robert M. Weetman
Kirsten K. Ness
Lonnie K. Zeltzer
Neyssa Marina
Amanda Termuhlen
Douglas C. Dover
A. T. Meadows
Gregory H. Reaman
Smita Bhatia
Norman E. Breslow
S.M. Davies
Kevin C. Oeffinger
Roger J. Packer
John D. Potter
Ann C. Mertens
Jackie Casallis
Jill Ginsberg
Brian Greffe
John D. Boice
Kathy Ruccione
Joseph P. Neglia
Sarah S. Donaldson
Yutaka Yasui
Joanna L. Perkins
A. Kim Ritchey
Roger L. Berkow
Holcombe E. Grier
Joseph Philip Neglia
Mark T. Greenberg
Dennis Deapen
Raymond J. Hutchinson
Terry A. Vik
Wendy M. Leisenring
ZoAnn E. Dreyer
Frederick B. Ruymann
Louise C. Strong
Teresa J. Vietti
Leslie L. Robison
Arthur R. Ablin
Daniel A. Mulrooney
Michael P. Link
Daniel M. Green
Jean M. Tersak
Source :
Cancer. 112:2071-2079
Publication Year :
2008
Publisher :
Wiley, 2008.

Abstract

BACKGROUND Limited data exist on the comprehensive assessment of late medical and social effects experienced by survivors of childhood and young adult acute myeloid leukemia (AML). METHODS This analysis included 272 5-year AML survivors who participated in the Childhood Cancer Survivor Study (CCSS). All patients were diagnosed at age ≤21 years between the years 1970 and 1986, and none underwent stem cell transplantation. Rates of survival, relapse, and late outcomes were analyzed. RESULTS The average follow-up was 20.5 years (range, 5–33 years). The overall survival rate was 97% at 10 years (95% confidence interval [95%CI], 94%–98%) and 94% at 20 years (95% CI, 90%–96%). Six survivors reported 8 recurrences. The cumulative incidence of recurrent AML was 6.6% at 10 years (95% CI, 3.7%–9.6%) and 8.6% at 20 years (95% CI, 5.1%–12.1%). Ten subsequent malignant neoplasms (SMN) were reported, including 4 with a history of radiation therapy, for a 20-year cumulative incidence of 1.7% (95% CI, 0.02%–3.4%). Six cardiac events were reported, for a 20-year cumulative incidence 4.7% (95% CI, 2.1%–7.3%). Half of the survivors reported a chronic medical condition and, compared with siblings, were at increased risk for severe or life-threatening chronic medical conditions (16% vs 5.8%; P < .001). Among those aged ≥25 years, the age-adjusted marriage rates were similar among survivors and the general United States population (57% for both) and lower compared with siblings (67%; P < .01). Survivors' college graduation rates were lower compared with siblings but higher than the general population (40% vs 52% vs 34%, respectively; P < .01). Employment rates were similar between survivors, siblings, and the general population (93%, 97.6%, and 95.8%, respectively). CONCLUSIONS Long-term survival from childhood AML ≥5-years after diagnosis was favorable. Late-occurring medical events remained a concern with socioeconomic achievement lower than expected within the individual family unit, although it was not different from the general United States population. Cancer 2008. © 2008 American Cancer Society.

Details

ISSN :
10970142 and 0008543X
Volume :
112
Database :
OpenAIRE
Journal :
Cancer
Accession number :
edsair.doi.dedup.....94a969f277bf28b1c23d22c6f44eafcf